Shares of Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.75 and traded as high as $0.96. Mesoblast shares last traded at $0.91, with a volume of 600 shares changing hands.
Mesoblast Stock Performance
The firm has a fifty day moving average of $0.79 and a two-hundred day moving average of $0.75.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What Are Dividend Achievers? An Introduction
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Investing in Travel Stocks Benefits
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
